In our series, the 50 significant additional PCa cases detected in men with serum PSA levels up to 3.0 ng/mL represented a likelihood of 24.3%, which is higher than that reported in men with PI-RADS 3 [44,45]. The gene discussed is KLK3; the disease is posterior cortical atrophy.